Arthneeti
Sale is live|00:00:00
Gujarat State Fertilizers & Chemicals LtdQ1 FY25

Gujarat State Fertilizers & Chemicals Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 164P/E: 9.8Market Cap: ₹6.8K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • FY '25 manufacturing volumes were 1.6 million tons, a 15% YoY growth.
  • For FY '26, volumes expected to remain stable or improve due to:
  • - Utilization of Sikka unit capacity increasing from current 60-70%.
  • - Availability of Phosphoric Acid stock and competitive pricing from foreign suppliers.
  • - Government support and policy interventions ensuring stable raw material supply.
  • Target sales of approximately 4.5 lakh metric tons (450,000 tons) in Q1 FY '26.
  • Optimistic fertilizer segment outlook supported by favorable monsoon and revised Nutrition Based Subsidy (NBS) rates increasing support for DAP and NPK fertilizers by ~17%-26%.
  • Industrial product segment to benefit from HX crystal II plant operating at full capacity and higher Ammonia trading volumes.
  • Overall, company aims to maintain or improve revenue and sales volumes in FY '26 aligned with government policies and market conditions.

Margin guidance

Category 3
  • GSFC expects volume growth or stable volumes in FY '26, leveraging increased capacity utilization at the Sikka unit (60%-70%) and secured phosphoric acid supplies.
  • Improved profitability in the industrial products (IP) segment is anticipated with full-scale operations of the HX crystal plant and higher ammonia trading volumes.
  • Fertilizer EBITDA per metric ton is projected around Rs. 3,000 for FY '26, supported by government compensation and better operational efficiencies.
  • Sulphuric Acid plant commissioning in H1 FY '26 will boost supply and profitability through outside sales at strong prices.
  • Caprolactam-Benzene spread is expected to remain supportive albeit volatile; ongoing industrial products expansion will strengthen margins.
  • The company's strong balance sheet, long-term debt-free status, and CAPEX on projects such as solar power and plant revamps provide a solid foundation for growth.
  • Overall, the company maintains an optimistic outlook for sustained earnings growth supported by production scale-up, product mix optimization, and policy support.

3 more insights locked — sign up free to unlock

Fundraise plans

  • There is no specific mention of any current or future fundraising through debt or equity in the transcript.
  • The company maintains a long-term debt-free capital structure, indicating no reliance on debt currently.
  • Focus is on capitalizing CAPEX projects with planned spending of around Rs. 600 crores in the next 6 months.
  • The company emphasizes a robust financial position with sufficient liquidity and net worth to fund CAPEX internally.
  • Any decision related to buyback or similar equity actions would be a board call but currently not feasible due to ongoing CAPEX commitments.
  • No explicit plans or announcements regarding raising funds through debt or equity were disclosed during the call.

Order book

  • The company is targeting sales of approximately 4.5 lakh metric tons in Q1 of Financial Year 2025-26.
  • Utilization of Sikka unit capacity is currently around 60%-70%, with expectations to improve further due to availability and competitive pricing of Phosphoric Acid from foreign suppliers.
  • Production volumes for FY '26 are expected to remain the same or improve compared to FY '25, where manufacturing volumes were 1.6 million tons, a 15% year-on-year growth.
  • The company continues to align its production and import strategies to maintain market continuity amid raw material and global supply challenges.

Capex plans

Yes
  • The Company is advancing its CAPEX plans aligned with strategic growth.
  • Recently commissioned a 15 MW solar power project at Charanka Patan.
  • Urea-II revamping project operating at full capacity, commissioning expected by end of May 2025.
  • Phase-1 of GIPCL 75 MW solar power project (25 MW) commissioned; Phase-2 expected by May 31, 2025.
  • Once fully operational, GIPCL project projected to save approximately Rs. 30 crores annually by replacing grid power with economical power.
  • Sulphuric Acid V project and Phosphoric Acid-Sulphuric Acid (PA-SA) projects scheduled for commissioning in the first half of FY 2026.
  • Capital expenditure of around Rs. 600 crores planned over next 6 months (including Rs. 453 crores for Urea and Rs. 300 crores for SA V).

How does Gujarat State Fertilizers & Chemicals Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature
1Gujarat State Fertilizers & Chemicals Ltd
Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Gujarat State Fertilizers & Chemicals Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio